Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
10.3390/cancers11101528
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/209544 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-209544 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2095442024-11-14T13:18:52Z Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma Poh, H.M. Chiou, Y.S. Chong, Q.Y. Chen, R.-M. Rangappa, K.S. Ma, L. Zhu, T. Kumar, A.P. Pandey, V. Basappa Lee, S.-C. Lobie, P.E. MEDICINE INST OF MOLECULAR & CELL BIOLOGY CANCER SCIENCE INSTITUTE OF SINGAPORE Acquired resistance Apoptosis Dose-dependent toxicity Doxorubicin Mammary carcinoma PI3K/AKT Trefoil factor 3 (TFF3) 10.3390/cancers11101528 Cancers 11 10 1528 2021-12-06T04:22:31Z 2021-12-06T04:22:31Z 2019 Article Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Lee, S.-C., Lobie, P.E. (2019). Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma. Cancers 11 (10) : 1528. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers11101528 2072-6694 https://scholarbank.nus.edu.sg/handle/10635/209544 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2019 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Acquired resistance Apoptosis Dose-dependent toxicity Doxorubicin Mammary carcinoma PI3K/AKT Trefoil factor 3 (TFF3) |
spellingShingle |
Acquired resistance Apoptosis Dose-dependent toxicity Doxorubicin Mammary carcinoma PI3K/AKT Trefoil factor 3 (TFF3) Poh, H.M. Chiou, Y.S. Chong, Q.Y. Chen, R.-M. Rangappa, K.S. Ma, L. Zhu, T. Kumar, A.P. Pandey, V. Basappa Lee, S.-C. Lobie, P.E. Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
description |
10.3390/cancers11101528 |
author2 |
MEDICINE |
author_facet |
MEDICINE Poh, H.M. Chiou, Y.S. Chong, Q.Y. Chen, R.-M. Rangappa, K.S. Ma, L. Zhu, T. Kumar, A.P. Pandey, V. Basappa Lee, S.-C. Lobie, P.E. |
format |
Article |
author |
Poh, H.M. Chiou, Y.S. Chong, Q.Y. Chen, R.-M. Rangappa, K.S. Ma, L. Zhu, T. Kumar, A.P. Pandey, V. Basappa Lee, S.-C. Lobie, P.E. |
author_sort |
Poh, H.M. |
title |
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
title_short |
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
title_full |
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
title_fullStr |
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
title_full_unstemmed |
Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
title_sort |
inhibition of tff3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://scholarbank.nus.edu.sg/handle/10635/209544 |
_version_ |
1821226700513476608 |